Introduced:
Feb 27, 2025
Policy Area:
Health
Congress.gov:
Bill Statistics
2
Actions
4
Cosponsors
0
Summaries
1
Subjects
1
Text Versions
Yes
Full Text
AI Summary
AI Summary
No AI Summary Available
Click the button above to generate an AI-powered summary of this bill using Claude.
The summary will analyze the bill's key provisions, impact, and implementation details.
Error generating summary
Latest Action
Feb 27, 2025
Referred to the House Committee on Energy and Commerce.
Actions (2)
Referred to the House Committee on Energy and Commerce.
Type: IntroReferral
| Source: House floor actions
| Code: H11100
Feb 27, 2025
Submitted in House
Type: Committee
| Source: Library of Congress
| Code: H12100
Feb 27, 2025
Subjects (1)
Health
(Policy Area)
Cosponsors (4)
(D-GA)
Feb 27, 2025
Feb 27, 2025
(D-DC)
Feb 27, 2025
Feb 27, 2025
(D-NY)
Feb 27, 2025
Feb 27, 2025
(D-FL)
Feb 27, 2025
Feb 27, 2025
Full Bill Text
Length: 2,000 characters
Version: Introduced in House
Version Date: Feb 27, 2025
Last Updated: Nov 15, 2025 6:25 AM
[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 172 Introduced in House
(IH) ]
<DOC>
119th CONGRESS
1st Session
H. RES. 172
Raising awareness for the sarcoma cancer chordoma.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
February 27, 2025
Mr. Johnson of Georgia (for himself, Mrs. McBath, Ms. Wilson of
Florida, Ms. Velazquez, and Ms. Norton) submitted the following
resolution; which was referred to the Committee on Energy and Commerce
_______________________________________________________________________
RESOLUTION
Raising awareness for the sarcoma cancer chordoma.
Whereas chordoma is a slow growing, yet aggressive bone cancer of the skull and
spine;
Whereas it strikes people of all ages and affects more than 25,000 individuals
worldwide;
Whereas, each year, thousands of people are diagnosed with chordoma including
about 300 people annually in the United States;
Whereas chordomas are among the most complicated tumors to treat due to
involvement of critical structures such as the brain stem, spinal cord,
and important nerves and arteries;
Whereas surgery or radiation performed by a skilled treatment team can be
curative for some patients, but even with the best care possible, the
recurrence rate remains high; and
Whereas no drugs are known to cure or effectively control the disease, meaning
that patients whose disease progresses after exhausting surgical and
radiation options have little hope for a full recovery: Now, therefore,
be it
Resolved, That it is the sense of the House of Representatives that
chordoma patients and families need increased funding and support for--
(1) accurate and early diagnosis;
(2) the development of new treatments, diagnostics, and
cures;
(3) fewer hurdles between research and new treatments; and
(4) patient-centric approaches to drug discovery and
development.
<all>
[From the U.S. Government Publishing Office]
[H. Res. 172 Introduced in House
(IH) ]
<DOC>
119th CONGRESS
1st Session
H. RES. 172
Raising awareness for the sarcoma cancer chordoma.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
February 27, 2025
Mr. Johnson of Georgia (for himself, Mrs. McBath, Ms. Wilson of
Florida, Ms. Velazquez, and Ms. Norton) submitted the following
resolution; which was referred to the Committee on Energy and Commerce
_______________________________________________________________________
RESOLUTION
Raising awareness for the sarcoma cancer chordoma.
Whereas chordoma is a slow growing, yet aggressive bone cancer of the skull and
spine;
Whereas it strikes people of all ages and affects more than 25,000 individuals
worldwide;
Whereas, each year, thousands of people are diagnosed with chordoma including
about 300 people annually in the United States;
Whereas chordomas are among the most complicated tumors to treat due to
involvement of critical structures such as the brain stem, spinal cord,
and important nerves and arteries;
Whereas surgery or radiation performed by a skilled treatment team can be
curative for some patients, but even with the best care possible, the
recurrence rate remains high; and
Whereas no drugs are known to cure or effectively control the disease, meaning
that patients whose disease progresses after exhausting surgical and
radiation options have little hope for a full recovery: Now, therefore,
be it
Resolved, That it is the sense of the House of Representatives that
chordoma patients and families need increased funding and support for--
(1) accurate and early diagnosis;
(2) the development of new treatments, diagnostics, and
cures;
(3) fewer hurdles between research and new treatments; and
(4) patient-centric approaches to drug discovery and
development.
<all>